Evidence map›Paper›PMID 41117068›Full record

ArticleAllergy2025

An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates.

Aurélie Mougel, Katia Lemdani, Nadine Serhan, Charlotte Hateb, Jonathan Bonnefoy, Samir Hamdi, William P M Worrall, Jasper B J Kamphuis, Léna Andrieux, Fabien Colaone and 11 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Aurélie MougelNeovacs SA, Suresnes, France.ORCID https://orcid.org/0000-0002-8761-080X
Katia LemdaniNeovacs SA, Suresnes, France.ORCID https://orcid.org/0000-0002-7222-6151
Nadine SerhanUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0001-9870-9875
Charlotte HatebUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0009-0006-9753-7243
Jonathan BonnefoyNeovacs SA, Suresnes, France.
Samir HamdiNeovacs SA, Suresnes, France.
William P M WorrallUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0003-2507-8173
Jasper B J KamphuisUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0002-8494-613X
Léna AndrieuxUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0009-0005-7664-0527
Fabien ColaoneNeovacs SA, Suresnes, France.
Rémi VieiraNeovacs SA, Suresnes, France.
Margot ZahmUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.
Adeline ChaubetUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.
Simon LachambreUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0009-0000-7992-8423
Rüçhan EkrenUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0001-6737-7281
Edouard LevequeUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0003-0002-729X
Laurent GuilleminaultUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.
Nicolas GaudenzioUniversity of Toulouse, Infinity, Inserm, CNRS, Toulouse, France.ORCID https://orcid.org/0000-0002-5648-509X
Béatrice DrouetNeovacs SA, Suresnes, France.
Vincent SerraNeovacs SA, Suresnes, France.
Laurent L ReberNeovacs SA, Suresnes, France.ORCID https://orcid.org/0000-0003-3384-6769

Funding

Agence Nationale de la RechercheEuropean Research CouncilFondation pour la Recherche MédicaleInstitut National de la Santé et de la Recherche MédicaleNEOVACS
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active immunizationallergyantibodyeczemainterleukin

Identifiers

PMID41117068
PMCPMC12666736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.